Literature DB >> 10919894

Iris lymphoma in a pediatric cardiac transplant recipient: clinicopathologic findings.

S M Chan1, C M Hutnik, J G Heathcote, R B Orton, D Banerjee.   

Abstract

PURPOSE: To report the unusual presentation of a confirmed iris lymphoma in the setting of posttransplant lymphoproliferative disorder.
DESIGN: Case report with clinicopathologic findings.
METHODS: The medical record was reviewed for clinical manifestations, course of disease, and pathologic and radiologic findings.
RESULTS: A 4-year-old girl who had undergone a cardiac transplant at 3 months of age was found to have unilateral iris lesions associated with granulomatous uveitis. Her condition was unresponsive to local and systemic steroids, so she underwent an iris biopsy that was found to contain a B cell-derived monoclonal lymphoproliferation. Treatment with systemic chemotherapy including cyclophosphamide and prednisone resulted in a transient, partial response. Localized radiotherapy induced total regression of the iris lesions. She continues to be observed and has been free of recurrence or metastasis for the past 12 months.
CONCLUSIONS: Because of the increased use of organ transplantation, eye care specialists should consider the diagnosis of intraocular lymphoma when confronted with uveitis-like syndrome unresponsive to topical steroid therapy. Although there are numerous treatment options for intraocular lymphoma, radiation therapy was found to be effective in the treatment of this case.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919894     DOI: 10.1016/s0161-6420(00)00172-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

1.  Intraocular lymphoma after cardiac transplantation: magnetic resonance imaging findings.

Authors:  Yi Kyung Kim; Hyung-Jin Kim; Kyung In Woo; Yoon-Duck Kim
Journal:  Korean J Radiol       Date:  2012-12-28       Impact factor: 3.500

2.  EBV-induced polymorphic lymphoproliferative disorder of the iris after heart transplantation.

Authors:  Jens Martin Rohrbach; Stefan Martin Kröber; Thomas Teufel; Rolf-Dieter Kortmann; Manfred Zierhut
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-09       Impact factor: 3.117

3.  Ocular adnexal non-Hodgkin's lymphoma: a review of epidemiology and risk factors.

Authors:  Roxana Moslehi; Maria J Schymura; Seema Nayak; F Bruce Coles
Journal:  Expert Rev Ophthalmol       Date:  2011-04

Review 4.  Primary vitreoretinal lymphoma.

Authors:  Kaustubh Mulay; Ritesh Narula; Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2015-03       Impact factor: 1.848

Review 5.  Primary vitreoretinal lymphoma: prevalence, impact, and management challenges.

Authors:  Ramesh Venkatesh; Bharathi Bavaharan; Padmamalini Mahendradas; Naresh Kumar Yadav
Journal:  Clin Ophthalmol       Date:  2019-02-14

Review 6.  Cytologic and Molecular Diagnostics for Vitreoretinal Lymphoma: Current Approaches and Emerging Single-Cell Analyses.

Authors:  Wei Jian Tan; Mona Meng Wang; Paola Ricciardi-Castagnoli; Anita Sook Yee Chan; Tong Seng Lim
Journal:  Front Mol Biosci       Date:  2021-01-11

7.  Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review).

Authors:  Yanxia Liu; Qingmin Yao; Feng Zhang
Journal:  Int J Oncol       Date:  2021-02-01       Impact factor: 5.650

8.  An unusual case report of primary vitreoretinal lymphoma.

Authors:  Shi Zhuan Tan; Laura R Steeples; Ramandeep Chhabra; Nicholas P Jones
Journal:  BMC Ophthalmol       Date:  2018-09-14       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.